See related Galvus tab information |
|
Manufacturer |
Novartis |
Distributor |
Hong Kong: Zuellig/Macau: Four Star |
Contents |
Vildagliptin |
Indications |
Type 2 DM as monotherapy or in dual combination w/ metformin, a sulphonylurea (SU), a thiazolidinedione (TZD) or insulin when diet, exercise & a single antidiabetic agent do not result in adequate glycaemic control.
Click to view Galvus detailed prescribing infomation |
Dosage |
Monotherapy or combination therapy w/ metformin, a TZD & insulin 50 mg once daily or 50 mg bd. Combination therapy w/ a SU 50 mg once daily.
Click to view Galvus detailed prescribing infomation |
Overdosage |
View Galvus overdosage for action to be taken in the event of an overdose. |
Administration |
May be taken with or without food |
Contraindications |
[Click for Galvus detailed prescribing infomation] |
Special Precautions |
Renal or hepatic impairment. Monitor liver function tests at baseline & regularly during therapy. Not to be used in patients w/ type 1 DM or for treatment of diabetic ketoacidosis. Pregnancy & lactation. Childn <18 yr.
Click to view Galvus detailed prescribing infomation |
Adverse Drug Reactions |
Dizziness, headache, constipation, peripheral oedema, tremor, asthenia, GI disturbances.
View ADR Monitoring Form |
Drug Interactions |
[Click for Galvus detailed prescribing infomation]
View more drug interactions with Galvus |
Description |
View Galvus description for details of the chemical structure and excipients (inactive components). |
Mechanism of Action |
View Galvus mechanism of action for pharmacodynamics and pharmacokinetics details. |
Presentation/Packing |
Form |
Packing |
Photo |
Galvus tablet |
Galvus 50 mg x 28's |
 |
Galvus 50 mg x 56's |
 |
|
|
Manufacturer: |
Novartis |
Distributor: |
Hong Kong: Zuellig
Macau: Four Star |
|
|
|
|